1 unchanged sentence
EXHIBIT INDEX
−Removed: Form of Class A Warrant (included as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on November 3, 2022 and incorporated herein by reference).
−Removed: Form of Class B Warrant (included as Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on November 3, 2022 and incorporated herein by reference).
−Removed: Form of Non-U.S.
−Removed: Subscription Agreement (included as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on November 3, 2022 and incorporated herein by reference).
−Removed: Subscription Agreement (included as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on November 3, 2022 and incorporated herein by reference).
−Removed: Lease Extending and Amending Agreement dated as of December 31, 2022 by and between Edesa Biotech Research, Inc.
−Removed: and 1968160 Ontario, Inc.
−Removed: (filed herewith).
Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
14 unchanged sentences
EDESA BIOTECH, INC.
−Removed: February 10, 2023
/s/ Kathi Niffenegger
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.